1. Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges
    Attila Oláh et al, 2017, Front. Immunol. CrossRef
  2. Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science
    Eric P. Baron, 2018, Headache: The Journal of Head and Face Pain CrossRef
  3. Cannabis for cancer – illusion or the tip of an iceberg: a review of the evidence for the use of Cannabis and synthetic cannabinoids in oncology
    Ilit Turgeman et al, 2018, Expert Opinion on Investigational Drugs CrossRef
  4. Accuracy of Medical Marijuana Claims Made by Popular Websites
    Katelyn D. Boatwright et al, 2018, Journal of Pharmacy Practice CrossRef
  5. The onus of cannabinoids in interrupting the molecular odyssey of breast cancer: A critical perspective on UPRER and beyond
    Safikur Rahman et al, 2019, Saudi Pharmaceutical Journal CrossRef
  6. Medical cannabis in the UK
    Alex Stevens, 2018, BMJ CrossRef
  7. Future Aspects for Cannabinoids in Breast Cancer Therapy
    Terézia Kisková et al, 2019, IJMS CrossRef
  8. Antitumor Cannabinoid Chemotypes: Structural Insights
    Paula Morales et al, 2019, Front. Pharmacol. CrossRef
  9. CBD loaded microparticles as a potential formulation to improve paclitaxel and doxorubicin-based chemotherapy in breast cancer
    A.I. Fraguas-Sánchez et al, 2019, International Journal of Pharmaceutics CrossRef
  10. Cannabinoids as anticancer therapeutic agents.
    Olga Kovalchuk et al, 2020, Cell Cycle CrossRef
  11. Can Hemp Help? Low-THC Cannabis and Non-THC Cannabinoids for the Treatment of Cancer
    Farjana Afrin et al, 2020, Cancers CrossRef
  12. Physician Attitudes and Perceptions of Complementary and Alternative Medicine (CAM): A Multicentre Italian Study
    Massimiliano Berretta et al, 2020, Front. Oncol. CrossRef
  13. Synergistic cytotoxic activity of cannabinoids from cannabis sativa against cutaneous T-cell lymphoma (CTCL) in-vitro and ex-vivo
    Moran Mazuz et al, 2020, Oncotarget CrossRef
  14. Cannabinoid CP55940 selectively induces apoptosis in Jurkat cells and in ex vivo T-cell acute lymphoblastic leukemia through H2O2 signaling mechanism
    Viviana Soto-Mercado et al, 2020, Leukemia Research CrossRef
  15. Enhancing ovarian cancer conventional chemotherapy through the combination with cannabidiol loaded microparticles
    A.I. Fraguas-Sánchez et al, 2020, European Journal of Pharmaceutics and Biopharmaceutics CrossRef
  16. Anti-proliferative and cytotoxic effect of cannabidiol on human cancer cell lines in presence of serum
    Alberto Sainz-Cort et al, 2020, BMC Res Notes CrossRef
  17. Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis
    Andrea M. Tomko et al, 2020, Cancers CrossRef
  18. Cannabidiol (CBD) as a Promising Anti-Cancer Drug.
    Emily S Seltzer et al, 2020, Cancers (Basel) CrossRef
  19. Cannabis and its Constituents for Cancer: History, Biogenesis, Chemistry and Pharmacological Activities
    Samridhi Lal et al, 2020, Pharmacological Research CrossRef
  20. The Role of Cannabinoids as Anticancer Agents in Pediatric Oncology
    Clara Andradas et al, 2021, Cancers CrossRef
  21. Therapeutic potential of cannabinoids in combination cancer therapy
    Pratibha Malhotra et al, 2021, Advances in Biological Regulation CrossRef
  22. Medical Cannabis in Oncology: a Valuable Unappreciated Remedy or an Undesirable Risk?
    Mahmoud Abu-Amna et al, 2021, Curr. Treat. Options in Oncol. CrossRef
  23. Assessment of Cannabidiol and Δ9-Tetrahydrocannabiol in Mouse Models of Medulloblastoma and Ependymoma
    Clara Andradas et al, 2021, Cancers CrossRef
  24. Overcoming Glucocorticoid Resistance in Acute Lymphoblastic Leukemia: Repurposed Drugs Can Improve the Protocol
    Miguel Olivas-Aguirre et al, 2021, Front. Oncol. CrossRef
  25. Pros and Cons of the Cannabinoid System in Cancer: Focus on Hematological Malignancies.
    Alessandro Allegra, 0 CrossRef
  26. THC shows activity against cultured Plasmodium falciparum
    Ana Carolina C. de Sousa et al, 2021, Bioorganic & Medicinal Chemistry Letters CrossRef
  27. In vitro anticancer activity and oxidative molecular damage by cannabidiol administered alone and in combination with epirubicin
    Margarita Zhelyazkova et al, 2021, Biotechnology & Biotechnological Equipment CrossRef
  28. A Comprehensive Review on the Techniques for Extraction of Bioactive Compounds from Medicinal Cannabis
    Hebah Muhsien Sabiah AL Ubeed et al, 2022, Molecules CrossRef
  29. Cannabidiol (CBD) in Cancer Management
    Kylie O’Brien, 2022, Cancers CrossRef
  30. Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer Care
    Donald I. Abrams, 2022, Integr Cancer Ther CrossRef
  31. Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics
    Gerhard Nahler, 2022, Pharm Med CrossRef
  32. The effects of cannabidiol via TRPV2 channel in chronic myeloid leukemia cells and its combination with imatinib
    Federica Maggi et al, 2022, Cancer Science CrossRef
  33. Combination of cannabidiol with low‑dose naltrexone increases the anticancer action of chemotherapy in vitro and in vivo
    Wai Liu et al, 2022, Oncol Rep CrossRef
  34. Medical Cannabis in Pediatric Oncology: Friend or Foe?
    Megan Malach et al, 2022, Pharmaceuticals CrossRef
  35. Cannabidiol on the Path from the Lab to the Cancer Patient: Opportunities and Challenges
    Miguel Olivas-Aguirre et al, 2022, Pharmaceuticals CrossRef
  36. Cannabis Biomolecule Effects on Cancer Cells and Cancer Stem Cells: Cytotoxic, Anti-Proliferative, and Anti-Migratory Activities
    Hadar Peeri et al, 2022, Biomolecules CrossRef
  37. Minor Phytocannabinoids: A Misleading Name but a Promising Opportunity for Biomedical Research
    Diego Caprioglio et al, 2022, Biomolecules CrossRef
  38. Natural products as chemo-radiation therapy sensitizers in cancers
    Sabah Nisar et al, 2022, Biomedicine & Pharmacotherapy CrossRef
  39. null
    Özge Boyacıoğlu et al, 2022 CrossRef